{"id":781134,"date":"2023-08-30T16:24:46","date_gmt":"2023-08-30T20:24:46","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/rapt-therapeutics-to-participate-in-several-upcoming-investor-conferences-in-september-2\/"},"modified":"2023-08-30T16:24:46","modified_gmt":"2023-08-30T20:24:46","slug":"rapt-therapeutics-to-participate-in-several-upcoming-investor-conferences-in-september-2","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/rapt-therapeutics-to-participate-in-several-upcoming-investor-conferences-in-september-2\/","title":{"rendered":"RAPT Therapeutics to Participate in Several Upcoming Investor Conferences in September"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"left\">SOUTH SAN FRANCISCO, Calif., Aug.  30, 2023  (GLOBE NEWSWIRE) &#8212; RAPT Therapeutics, Inc. (Nasdaq: RAPT), a clinical-stage, immunology-based therapeutics company focused on discovering, developing and commercializing oral small molecule therapies for patients with significant unmet needs in inflammatory diseases and oncology, today announced that members of the RAPT management team will participate in the following investor conferences in September:<\/p>\n<ul type=\"disc\">\n<li>\n          <strong>Wells Fargo 2023 Healthcare Conference <\/strong>\u2013 Fireside chat on Wednesday, September 6, 2023 at 8:00 a.m. ET <\/p>\n<\/li>\n<li>\n          <strong>H.C. Wainwright 25<\/strong><br \/>\n          <sup><br \/>\n            <strong>th<\/strong><br \/>\n          <\/sup><br \/>\n          <strong> Annual Global Investment Conference <\/strong>\u2013 Presentation on Monday, September 11, 2023 at 2:00 p.m. ET <\/p>\n<\/li>\n<li>\n          <strong>Stifel 2023 Immunology and Inflammation Virtual Summit <\/strong>\u2013 Fireside chat on Tuesday, September 19, 2023 at 3:45 p.m. ET <\/p>\n<\/li>\n<li>\n          <strong>Cantor Global Healthcare Conference<\/strong> \u2013 Presentation on Tuesday, September 26, 2023 at 10:35 a.m. ET<\/li>\n<\/ul>\n<p>To access the available live webcasts or subsequent archived recordings of the discussions and presentations, please visit the RAPT Therapeutics website at <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=9EvrhSVZcJQi8696quDRYEFJO_30MbPoVx8vT2NG5PlEODDz5fycGi_RGxQ5GFZG5Ys6GHEVXGflziwfVPeRV12lQd8EvtH5VWohdDPfVlVw1AWAWvBNnlV0GdAsgg9I1nW8cCwhSTIcmKcdZFWEQZ94cr3Ca4NafCPo2y9RMQI=\" rel=\"nofollow noopener\" target=\"_blank\">https:\/\/investors.rapt.com\/events-and-presentations<\/a>.<\/p>\n<p>\n        <strong>About RAPT Therapeutics, Inc.<\/strong><br \/>\n        <br \/>RAPT Therapeutics is a clinical-stage, immunology-based therapeutics company focused on discovering, developing and commercializing oral small molecule therapies for patients with significant unmet needs in inflammatory diseases and oncology. Utilizing its proprietary discovery and development engine, the Company is developing highly selective small molecules designed to modulate the critical immune drivers underlying these diseases. RAPT has discovered and advanced two unique drug candidates, RPT193 and FLX475, each targeting C-C motif chemokine receptor 4 (CCR4), for the treatment of inflammation and cancer, respectively. The Company is also pursuing a range of targets that are in the discovery stage of development.<\/p>\n<p>\n        <strong>Investor Contact:<\/strong><br \/>\n        <br \/>Sylvia Wheeler<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=9ZXLqaOKZc5IiE61KxIeFFmty1QQm7bPZyn6syi9u-qvPvL_lDL5_vRTUZeXB7citd83uEQ6dW8wXL4NDKvZtEEDUMYL2uquM8KJF3qm3OosgJneJzgqkZ6kFEdDtWub\" rel=\"nofollow noopener\" target=\"_blank\">swheeler@wheelhouselsa.com<\/a><\/p>\n<p>\n        <strong>Media Contact:<\/strong><br \/>\n        <br \/>Aljanae Reynolds<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=9zdP3LYq33JetKwK_AK4UcctWpOfN0yEmWKaQMIUCOh4QsREfoZCXbpAmcoqYEAnBLNH1OMSQozEt9zZXPcoVF6y7bgesz7ArH06-6AR_uuOZWCTC-axnx_j8c-zEyu_\" rel=\"nofollow noopener\" target=\"_blank\">areynolds@wheelhouselsa.com<\/a><\/p>\n<p>      <img decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODkxMzkyMSM1NzkxMzE5IzIwMjkyMDk=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" src=\"https:\/\/ml.globenewswire.com\/media\/NjAxOGJjMWYtNzc4Ni00OTZlLTg1MWEtYjdkNGQ2ZGE5OWY5LTEwNDA3ODA=\/tiny\/RAPT-Therapeutics-Inc-.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>SOUTH SAN FRANCISCO, Calif., Aug. 30, 2023 (GLOBE NEWSWIRE) &#8212; RAPT Therapeutics, Inc. (Nasdaq: RAPT), a clinical-stage, immunology-based therapeutics company focused on discovering, developing and commercializing oral small molecule therapies for patients with significant unmet needs in inflammatory diseases and oncology, today announced that members of the RAPT management team will participate in the following investor conferences in September: Wells Fargo 2023 Healthcare Conference \u2013 Fireside chat on Wednesday, September 6, 2023 at 8:00 a.m. ET H.C. Wainwright 25 th Annual Global Investment Conference \u2013 Presentation on Monday, September 11, 2023 at 2:00 p.m. ET Stifel 2023 Immunology and Inflammation Virtual Summit \u2013 Fireside chat on Tuesday, September 19, 2023 at 3:45 p.m. ET Cantor Global Healthcare Conference \u2013 Presentation &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/rapt-therapeutics-to-participate-in-several-upcoming-investor-conferences-in-september-2\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;RAPT Therapeutics to Participate in Several Upcoming Investor Conferences in September&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-781134","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>RAPT Therapeutics to Participate in Several Upcoming Investor Conferences in September - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/rapt-therapeutics-to-participate-in-several-upcoming-investor-conferences-in-september-2\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"RAPT Therapeutics to Participate in Several Upcoming Investor Conferences in September - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"SOUTH SAN FRANCISCO, Calif., Aug. 30, 2023 (GLOBE NEWSWIRE) &#8212; RAPT Therapeutics, Inc. (Nasdaq: RAPT), a clinical-stage, immunology-based therapeutics company focused on discovering, developing and commercializing oral small molecule therapies for patients with significant unmet needs in inflammatory diseases and oncology, today announced that members of the RAPT management team will participate in the following investor conferences in September: Wells Fargo 2023 Healthcare Conference \u2013 Fireside chat on Wednesday, September 6, 2023 at 8:00 a.m. ET H.C. Wainwright 25 th Annual Global Investment Conference \u2013 Presentation on Monday, September 11, 2023 at 2:00 p.m. ET Stifel 2023 Immunology and Inflammation Virtual Summit \u2013 Fireside chat on Tuesday, September 19, 2023 at 3:45 p.m. ET Cantor Global Healthcare Conference \u2013 Presentation &hellip; Continue reading &quot;RAPT Therapeutics to Participate in Several Upcoming Investor Conferences in September&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/rapt-therapeutics-to-participate-in-several-upcoming-investor-conferences-in-september-2\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2023-08-30T20:24:46+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODkxMzkyMSM1NzkxMzE5IzIwMjkyMDk=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/rapt-therapeutics-to-participate-in-several-upcoming-investor-conferences-in-september-2\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/rapt-therapeutics-to-participate-in-several-upcoming-investor-conferences-in-september-2\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"RAPT Therapeutics to Participate in Several Upcoming Investor Conferences in September\",\"datePublished\":\"2023-08-30T20:24:46+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/rapt-therapeutics-to-participate-in-several-upcoming-investor-conferences-in-september-2\\\/\"},\"wordCount\":267,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/rapt-therapeutics-to-participate-in-several-upcoming-investor-conferences-in-september-2\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODkxMzkyMSM1NzkxMzE5IzIwMjkyMDk=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/rapt-therapeutics-to-participate-in-several-upcoming-investor-conferences-in-september-2\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/rapt-therapeutics-to-participate-in-several-upcoming-investor-conferences-in-september-2\\\/\",\"name\":\"RAPT Therapeutics to Participate in Several Upcoming Investor Conferences in September - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/rapt-therapeutics-to-participate-in-several-upcoming-investor-conferences-in-september-2\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/rapt-therapeutics-to-participate-in-several-upcoming-investor-conferences-in-september-2\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODkxMzkyMSM1NzkxMzE5IzIwMjkyMDk=\",\"datePublished\":\"2023-08-30T20:24:46+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/rapt-therapeutics-to-participate-in-several-upcoming-investor-conferences-in-september-2\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/rapt-therapeutics-to-participate-in-several-upcoming-investor-conferences-in-september-2\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/rapt-therapeutics-to-participate-in-several-upcoming-investor-conferences-in-september-2\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODkxMzkyMSM1NzkxMzE5IzIwMjkyMDk=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODkxMzkyMSM1NzkxMzE5IzIwMjkyMDk=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/rapt-therapeutics-to-participate-in-several-upcoming-investor-conferences-in-september-2\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"RAPT Therapeutics to Participate in Several Upcoming Investor Conferences in September\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"RAPT Therapeutics to Participate in Several Upcoming Investor Conferences in September - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/rapt-therapeutics-to-participate-in-several-upcoming-investor-conferences-in-september-2\/","og_locale":"en_US","og_type":"article","og_title":"RAPT Therapeutics to Participate in Several Upcoming Investor Conferences in September - Market Newsdesk","og_description":"SOUTH SAN FRANCISCO, Calif., Aug. 30, 2023 (GLOBE NEWSWIRE) &#8212; RAPT Therapeutics, Inc. (Nasdaq: RAPT), a clinical-stage, immunology-based therapeutics company focused on discovering, developing and commercializing oral small molecule therapies for patients with significant unmet needs in inflammatory diseases and oncology, today announced that members of the RAPT management team will participate in the following investor conferences in September: Wells Fargo 2023 Healthcare Conference \u2013 Fireside chat on Wednesday, September 6, 2023 at 8:00 a.m. ET H.C. Wainwright 25 th Annual Global Investment Conference \u2013 Presentation on Monday, September 11, 2023 at 2:00 p.m. ET Stifel 2023 Immunology and Inflammation Virtual Summit \u2013 Fireside chat on Tuesday, September 19, 2023 at 3:45 p.m. ET Cantor Global Healthcare Conference \u2013 Presentation &hellip; Continue reading \"RAPT Therapeutics to Participate in Several Upcoming Investor Conferences in September\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/rapt-therapeutics-to-participate-in-several-upcoming-investor-conferences-in-september-2\/","og_site_name":"Market Newsdesk","article_published_time":"2023-08-30T20:24:46+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODkxMzkyMSM1NzkxMzE5IzIwMjkyMDk=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/rapt-therapeutics-to-participate-in-several-upcoming-investor-conferences-in-september-2\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/rapt-therapeutics-to-participate-in-several-upcoming-investor-conferences-in-september-2\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"RAPT Therapeutics to Participate in Several Upcoming Investor Conferences in September","datePublished":"2023-08-30T20:24:46+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/rapt-therapeutics-to-participate-in-several-upcoming-investor-conferences-in-september-2\/"},"wordCount":267,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/rapt-therapeutics-to-participate-in-several-upcoming-investor-conferences-in-september-2\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODkxMzkyMSM1NzkxMzE5IzIwMjkyMDk=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/rapt-therapeutics-to-participate-in-several-upcoming-investor-conferences-in-september-2\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/rapt-therapeutics-to-participate-in-several-upcoming-investor-conferences-in-september-2\/","name":"RAPT Therapeutics to Participate in Several Upcoming Investor Conferences in September - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/rapt-therapeutics-to-participate-in-several-upcoming-investor-conferences-in-september-2\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/rapt-therapeutics-to-participate-in-several-upcoming-investor-conferences-in-september-2\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODkxMzkyMSM1NzkxMzE5IzIwMjkyMDk=","datePublished":"2023-08-30T20:24:46+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/rapt-therapeutics-to-participate-in-several-upcoming-investor-conferences-in-september-2\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/rapt-therapeutics-to-participate-in-several-upcoming-investor-conferences-in-september-2\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/rapt-therapeutics-to-participate-in-several-upcoming-investor-conferences-in-september-2\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODkxMzkyMSM1NzkxMzE5IzIwMjkyMDk=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODkxMzkyMSM1NzkxMzE5IzIwMjkyMDk="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/rapt-therapeutics-to-participate-in-several-upcoming-investor-conferences-in-september-2\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"RAPT Therapeutics to Participate in Several Upcoming Investor Conferences in September"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/781134","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=781134"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/781134\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=781134"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=781134"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=781134"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}